Camilla Simpson
Director/Board Member bei SPRUCE BIOSCIENCES, INC.
Vermögen: - $ am 31.03.2024
Profil
Camilla V.
Simpson is the founder and currently holds the position of President & Managing Member at Rare Strategic LLC, which was founded in 2019.
She is also currently the Chief Executive Officer & Director at Zehna Therapeutics, Inc., starting in 2021.
Additionally, she serves as an Independent Director at Spruce Biosciences, Inc. since 2017, as a Director at Aristea Therapeutics, Inc. since 2019, as a Director at Dyve Biosciences, Inc. since 2020, and as an Independent Director at GRI Bio, Inc. since 2023.
In her former positions, Ms. Simpson worked as a Director at Vallon Pharmaceuticals, Inc. and held the role of Senior VP & Head-Product Portfolio Development at BioMarin Pharmaceutical, Inc. from 2017 to 2019.
She also worked as the VP-Regulatory Affairs & Business Development at Shire Pharmaceuticals, Inc.Ms. Simpson completed her graduate studies at the University of London and her undergraduate studies at Kingston University and the National University of Ireland Galway.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC.
-.--% | 25.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
GRI BIO, INC.
-.--% | 31.12.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Camilla Simpson
| Unternehmen | Position | Beginn |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director/Board Member | 13.11.2017 |
| GRI BIO, INC. | Director/Board Member | 24.04.2023 |
| Rare Strategic LLC | Founder | 01.04.2019 |
Dyve Biosciences, Inc.
 Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Director/Board Member | 01.12.2020 |
Aristea Therapeutics, Inc.
 Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Director/Board Member | 01.11.2019 |
Zehna Therapeutics, Inc.
 Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Chief Executive Officer | 01.04.2021 |
Ehemalige bekannte Positionen von Camilla Simpson
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.04.2019 |
| GRI BIOPAR | Director/Board Member | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | General Counsel | - |
Ausbildung von Camilla Simpson
| University of London | Graduate Degree |
| Kingston University | Undergraduate Degree |
| National University of Ireland Galway | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| GRI BIO, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Aristea Therapeutics, Inc.
Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Health Technology |
Dyve Biosciences, Inc.
Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Health Technology |
| Rare Strategic LLC | |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
Zehna Therapeutics, Inc.
Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Health Technology |
